816.51MMarket Cap-11500P/E (TTM)
2.600High2.450Low1.51MVolume2.520Open2.530Pre Close3.80MTurnover1.65%Turnover RatioLossP/E (Static)322.73MShares8.41052wk High1.06P/B232.55MFloat Cap2.26052wk Low--Dividend TTM91.92MShs Float34.430Historical High--Div YieldTTM5.93%Amplitude2.260Historical Low2.509Avg Price1Lot Size
Thoughtworks Stock Forum
ColumnsBiotechnology Stocks Climbing on Earnings and Test Results: What to Watch
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
Daily alerts recap 🔥 ALL STARS 🌟 45%+
ColumnsUS Top Gap Ups and Downs on 8/8: LLY, FOX, TWKS, DDOG and More
Gap Ups
1. $Novo-Nordisk A/S(NVO.US)$ - up 13.4%
2. $Eli Lilly and Co(LLY.US)$ - up 10.5%
3. $James Hardie Industries(JHX.US)$ - up 10.1%
4. $New York Times(NYT.US)$ - up 3.3%
5. $POSCO(PKX.US)$ - up 2.9%
6. $Fox Corp-B(FOX.US)$ - up 2.8%
7. $Fox Corp-A(FOXA.US)$ - up 2.8%
8. $West Pharmaceutical Services(WST.US)$ - up 2.5...
8/9 watchlist ⚡️
$Akamai(AKAM.US)$$Bruush Oral Care(BRSH.US)$$Extra Space Storage Inc(EXR.US)$$INVO Bioscience(INVO.US)$$Leju Holdings(LEJU.US)$$908 Devices(MASS.US)$$Marqeta(MQ.US)$$Penn Entertainment(PENN.US)$$Proterra(PTRA.US)$$Salarius Pharmaceuticals(SLRX.US)$$Super Micro Computer(SMCI.US)$$Tango Therapeutics(TNGX.US)$$Thoughtworks(TWKS.US)$$Twilio(TWLO.US)$$Wynn Resorts(WYNN.US)$
ColumnsDigital IT Services Preview | Not Out of the Woods Yet On Negative Estimate Revision Risk
The Digital IT Services group is expected to see a downside risk to its estimates, given weak demand for project-based services and possible delays in bookings ramp. Although snap-back potential to pre-pandemic growth rates is seen at some point next year, there is still caution in the group until stability in estimates is observed. Revision risk is possible, and negative revision trends have be...
good time to buy
No comment yet